At Vetter, we use a broad range of analytical testing on APIs, in-process samples, semi-finished products, and finished products.
Batch releases are conducted using utilities, cleanrooms, and processes that are routinely monitored and audited according to cGMP requirements and FDA regulations. Our own Qualified Persons provide oversee the release process of all medications we supply to patients worldwide.
Our comprehensive range of compendial and product specific analytical capabilities including physico-chemical, biochemical, and microbiological testing, aligns and supports optimally streamline quick-release testing of your compound.
Using those robust and proven testing methodologies, we assess a full spectrum of product attributes to verify they meet approved specifications for release – including purity, concentration, consistency, identity, safety, and more.
Our manufacturing processes are guided by a robust, end-to-end control strategy, with regular in-process testing to ensure efficient, cGMP-compliant production, high-quality outputs, and complete documentation.
All these controls are executed in accordance with the valid specification documents (SOPs, IPC specifications, manufacturing regulations, etc.), and are performed by fully trained and qualified employees using Quality Control-approved methods.
